SVRA: Savara Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 652.25
Enterprise Value ($M) 661.88
Book Value ($M) 121.86
Book Value / Share 0.88
Price / Book 5.35
NCAV ($M) 109.75
NCAV / Share 0.79
Price / NCAV 5.94

Profitability (mra)
Return on Invested Capital (ROIC) -0.43
Return on Assets (ROA) -0.50
Return on Equity (ROE) -0.66

Liquidity (mrq)
Quick Ratio 14.90
Current Ratio 14.90

Balance Sheet (mrq) ($M)
Current Assets 146.19
Assets 158.29
Liabilities 36.43
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -59.21
Net Income -54.70
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -51.06
Cash from Investing -57.12
Cash from Financing 82.78

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
04-12 13D/A Bain Capital Life Sciences Fund II, L.P. 9.99 2.34
02-14 13G/A Venrock Healthcare Capital Partners II, L.P. 2.60 -44.90
02-14 13G/A Zambon Spa 3.46 -0.29
02-13 13G/A Caxton Corp 0.30 -94.88
02-13 13G Prudential Financial Inc 7.23
02-08 13G Jennison Associates Llc 6.50
02-07 13G/A Adage Capital Partners Gp, L.l.c. 5.64 11.27
02-01 13G/A Farallon Capital Partners, L.P. 9.99 24.23
01-31 13G BlackRock Inc. 5.40 132.07
07-26 13D/A Growth Equity Opportunities 17, LLC 18.10 1.38
07-25 13G TCG Crossover GP I, LLC 7.40

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-07 10-K Form 10-K
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-17 160,471 742,222 21.62
2024-05-16 84,263 373,729 22.55
2024-05-15 96,963 669,384 14.49
2024-05-14 107,154 685,328 15.64
2024-05-13 163,969 699,764 23.43

(click for more detail)

Similar Companies
SRRK – Scholar Rock Holding Corporation STOK – Stoke Therapeutics, Inc.
STTK – Shattuck Labs, Inc. SWTX – SpringWorks Therapeutics, Inc.
SYRE – Spyre Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io